Gillian Kay

2.1k total citations
48 papers, 1.7k citations indexed

About

Gillian Kay is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Gillian Kay has authored 48 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 13 papers in Immunology and 7 papers in Oncology. Recurrent topics in Gillian Kay's work include Mast cells and histamine (9 papers), RNA modifications and cancer (9 papers) and RNA Research and Splicing (8 papers). Gillian Kay is often cited by papers focused on Mast cells and histamine (9 papers), RNA modifications and cancer (9 papers) and RNA Research and Splicing (8 papers). Gillian Kay collaborates with scholars based in Israel, United Kingdom and United States. Gillian Kay's co-authors include M. D. Lilly, Ehud Razin, Hovav Nechushtan, Marta Weinstock, Tatyana Poltyrev, E. M. Crook, Nora Tarcic, Gilmor I. Keshet, Irit Carmi-Levy and D.M. Kemeny and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Gillian Kay

48 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian Kay Israel 25 967 310 154 145 129 48 1.7k
Raymond N. Hiramoto United States 21 730 0.8× 405 1.3× 205 1.3× 166 1.1× 149 1.2× 146 2.0k
Yanhua Zhu China 24 1.4k 1.4× 230 0.7× 97 0.6× 271 1.9× 130 1.0× 85 2.6k
Vera Brinks Netherlands 22 871 0.9× 587 1.9× 270 1.8× 140 1.0× 70 0.5× 38 1.9k
Ning Huang China 31 1.3k 1.4× 480 1.5× 74 0.5× 253 1.7× 90 0.7× 102 2.9k
S Stein United States 30 2.2k 2.3× 224 0.7× 85 0.6× 211 1.5× 301 2.3× 48 3.1k
He Zhu United States 24 1.4k 1.4× 151 0.5× 139 0.9× 222 1.5× 87 0.7× 129 2.3k
Carla Raggi Italy 19 1.8k 1.9× 286 0.9× 93 0.6× 138 1.0× 184 1.4× 42 2.5k
Ran Wei China 23 745 0.8× 166 0.5× 71 0.5× 346 2.4× 62 0.5× 108 1.7k
Walter Sierralta Chile 25 1.0k 1.1× 144 0.5× 31 0.2× 152 1.0× 149 1.2× 78 2.2k
Yitzhak Koch Israel 34 775 0.8× 238 0.8× 145 0.9× 116 0.8× 125 1.0× 107 3.2k

Countries citing papers authored by Gillian Kay

Since Specialization
Citations

This map shows the geographic impact of Gillian Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Kay more than expected).

Fields of papers citing papers by Gillian Kay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Kay. The network helps show where Gillian Kay may publish in the future.

Co-authorship network of co-authors of Gillian Kay

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Kay. A scholar is included among the top collaborators of Gillian Kay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Kay. Gillian Kay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kay, Gillian, et al.. (2024). The spectrum of pre‐mRNA splicing in autism. Wiley Interdisciplinary Reviews - RNA. 15(2). 5 indexed citations
2.
Nevo, Yuval, Inbar Plaschkes, Gillian Kay, et al.. (2023). Isoforms of the TAL1 transcription factor have different roles in hematopoiesis and cell growth. PLoS Biology. 21(6). e3002175–e3002175. 5 indexed citations
3.
Kay, Gillian, et al.. (2021). VEGFA’s distal enhancer regulates its alternative splicing in CML. NAR Cancer. 3(3). zcab029–zcab029. 8 indexed citations
4.
Kay, Gillian, et al.. (2021). KDM3A regulates alternative splicing of cell-cycle genes following DNA damage. RNA. 27(11). 1353–1362. 11 indexed citations
5.
Nevo, Yuval, Gillian Kay, Mark Temper, et al.. (2020). Splicing Factor Transcript Abundance in Saliva as a Diagnostic Tool for Breast Cancer. Genes. 11(8). 880–880. 7 indexed citations
6.
Kay, Gillian, et al.. (2020). Splicing to Keep Cycling: The Importance of Pre-mRNA Splicing during the Cell Cycle. Trends in Genetics. 37(3). 266–278. 23 indexed citations
7.
Nevo, Yuval, et al.. (2019). Regulation of alternative splicing by p300-mediated acetylation of splicing factors. RNA. 25(7). 813–824. 29 indexed citations
8.
Landolina, Nadine, Miri Assayag, Inbal Rachmin, et al.. (2016). Pyruvate dehydrogenase has a major role in mast cell function, and its activity is regulated by mitochondrial microphthalmia transcription factor. Journal of Allergy and Clinical Immunology. 140(1). 204–214.e8. 30 indexed citations
9.
Rachmin, Inbal, Eliahu Golomb, Rоnen Beeri, et al.. (2015). FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy. International Journal of Cardiology. 195. 85–94. 13 indexed citations
10.
Kay, Gillian, Sagi Tshori, Hovav Nechushtan, et al.. (2014). Mitochondrial STAT3 plays a major role in IgE-antigen–mediated mast cell exocytosis. Journal of Allergy and Clinical Immunology. 134(2). 460–469.e10. 67 indexed citations
11.
Ofir‐Birin, Yifat, Sagi Tshori, Gillian Kay, et al.. (2012). Transcription factor E3, a major regulator of mast cell–mediated allergic response. Journal of Allergy and Clinical Immunology. 129(5). 1357–1366.e5. 27 indexed citations
12.
Nechushtan, Hovav, et al.. (2010). The enigma of the role of Protein inhibitor of Activated STAT3 (PIAS3) in the immune response. Trends in Immunology. 31(5). 199–204. 45 indexed citations
13.
Kay, Gillian, et al.. (2009). A Specific Epitope of Protein Inhibitor of Activated STAT3 Is Responsible for the Induction of Apoptosis in Rat Transformed Mast Cells. The Journal of Immunology. 182(4). 2168–2175. 17 indexed citations
14.
Carmi-Levy, Irit, Gillian Kay, Jung Min Han, et al.. (2009). LysRS Serves as a Key Signaling Molecule in the Immune Response by Regulating Gene Expression. Molecular Cell. 34(5). 603–611. 137 indexed citations
15.
Carmi-Levy, Irit, et al.. (2008). Diadenosine Tetraphosphate Hydrolase Is Part of the Transcriptional Regulation Network in Immunologically Activated Mast Cells. Molecular and Cellular Biology. 28(18). 5777–5784. 40 indexed citations
16.
Tshori, Sagi, et al.. (2007). Microphthalmia Transcription Factor Isoforms in Mast Cells and the Heart. Molecular and Cellular Biology. 27(11). 3911–3919. 25 indexed citations
18.
Poltyrev, Tatyana, Gilmor I. Keshet, Gillian Kay, & Marta Weinstock. (1996). Role of experimental conditions in determining differences in exploratory behavior of prenatally stressed rats. Developmental Psychobiology. 29(5). 453–462. 101 indexed citations
19.
Kay, Gillian, et al.. (1994). The lymphoblast β-adrenergic receptor in bipolar depressed patients: effect of chronic incubation with lithium chloride. Journal of Affective Disorders. 30(3). 185–192. 8 indexed citations
20.
Glue, Paul, et al.. (1991). Effects of chronic α2-adrenoceptor blockade on platelet and lymphocyte adrenoceptor binding in normal volunteers. Life Sciences. 49(8). PL21–PL25. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026